| The goal of the biotech industry is to create actual treatments for unmet medical needs. Biotechnology start-ups must take technology to market through a venture shaped by a specific business model, whether explicitly considered or implicitly embodied in the act of innovation. The inherent value of a technology remains latent until it is commercialised in some way. Obviously, the extent to which its value is realised depends upon the manner in which that takes place. Thus, technology managers must expand their perspectives in order to find the right business model, or 'the architecture of revenue' in order to capture value. |
